Business

Why Arrowhead Shot Sky-High, While Chief Rival Ionis Toppled - Investor's Business Daily

IB

Published by Investor's Business Daily 22 July 2026 at 17:05

Why Arrowhead Shot Sky-High, While Chief Rival Ionis Toppled - Investor's Business Daily — Image · Investor's Business Daily

What the report says

Arrowhead Pharmaceuticals' triglycerides-buster hit the "best-case scenario" in two studies Wednesday.

Read the full report at Investor's Business Daily →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting